+499.5%
MRNA vs PTEN
+135.2%
+364.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PTEN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.0% | -1.2% | -2.3% |
| 7D | +5.5% | +0.7% | +4.8% | +5.6% |
| 30D | +158.7% | +31.2% | +127.5% | +162.0% |
| 3M | +182.1% | +2.0% | +180.1% | +191.1% |
| 6M | +151.8% | +42.4% | +109.4% | +141.1% |
| YTD | +393.6% | +109.2% | +284.4% | +330.4% |
| 1Y | +499.5% | +122.3% | +377.2% | +412.8% |
| All | +499.5% | +135.2% | +364.2% | +412.8% |
Cumulative growth
Daily Returns
Daily percentage return beside PTEN.
Daily Out/Under-Performance
Portfolio return minus PTEN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PTEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PTEN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling